Publicacións (173) Publicacións de Jose Manuel Cameselle Teijeiro

2024

  1. Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)

    Nature Communications

  2. Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)

    Nature Communications

  3. Cribriform morular thyroid carcinoma: Clinicopathological and molecular basis for both a preventive and therapeutic approach for a rare tumor (Review)

    Oncology reports, Vol. 52, Núm. 3

  4. dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Cribriform morular thyroid carcinoma: a case report with pathological, immunohistochemical, and molecular findings suggesting an origin from follicular cells (or their endodermal precursors)

    Virchows Archiv, Vol. 482, Núm. 3, pp. 615-623

  2. Should we suspect primary aldosteronism in patients with hypokalaemic rhabdomyolysis? A systematic review

    Frontiers in Endocrinology, Vol. 14

2022

  1. Adrenal Medullary Hyperplasia: An Under the Radar Cause of Endocrine Hypertension

    American Journal of the Medical Sciences, Vol. 363, Núm. 1, pp. 64-68

  2. Changes and Perspectives in the New 2022 WHO Classification of Thyroid Neoplasms

    Revista Espanola de Patologia

  3. Histopathological Features of Pendred Syndrome Thyroids Align with Differences in the Expression of Thyroid-Specific Markers, Apical Iodide Transporters, and Ciliogenesis Process

    Endocrine Pathology, Vol. 33, Núm. 4, pp. 484-493

  4. Single-cell mtDNA heteroplasmy in colorectal cancer

    Genomics, Vol. 114, Núm. 2

  5. Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys

    Frontiers in Endocrinology, Vol. 13

2021

  1. Exome sequencing of early-onset patients supports genetic heterogeneity in colorectal cancer

    Scientific Reports, Vol. 11, Núm. 1

  2. Inherited Follicular Epithelial-Derived Thyroid Carcinomas: From Molecular Biology to Histological Correlates

    Endocrine Pathology, Vol. 32, Núm. 1, pp. 77-101

  3. Molecular Pathology of Non-familial Follicular Epithelial–Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification

    Endocrine Pathology, Vol. 32, Núm. 1, pp. 44-62

  4. PD-L1 expression and immune cells in anaplastic carcinoma and poorly differentiated carcinoma of the human thyroid gland: A retrospective study

    Oncology Letters, Vol. 22, Núm. 1

  5. Pathological thyroid findings in amiodarone-induced thyrotoxicosis

    Revista Espanola de Patologia, Vol. 54, Núm. 2, pp. 123-126

  6. Protein Extraction From FFPE Kidney Tissue Samples: A Review of the Literature and Characterization of Techniques

    Frontiers in Medicine, Vol. 8

  7. Rate of non-invasive follicular thyroid neoplasms with papillary-like nuclear features depends on pathologist’s criteria: a multicentre retrospective Southern European study with prolonged follow-up

    Endocrine, Vol. 73, Núm. 1, pp. 131-140

  8. The Authors Reply PMC and PMT: Real Medicine and Not Just Biology

    American Journal of Surgical Pathology

2020

  1. A novel nanoproteomic approach for the identification of molecular targets associated with thyroid tumors

    Nanomaterials, Vol. 10, Núm. 12, pp. 1-20